Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.

Currie G, Taylor AH, Fujita T, Ohtsu H, Lindhardt M, Rossing P, Boesby L, Edwards NC, Ferro CJ, Townend JN, van den Meiracker AH, Saklayen MG, Oveisi S, Jardine AG, Delles C, Preiss DJ, Mark PB.

BMC Nephrol. 2016 Sep 8;17(1):127. doi: 10.1186/s12882-016-0337-0.

2.

Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.

Rutherford E, Talle MA, Mangion K, Bell E, Rauhalammi SM, Roditi G, McComb C, Radjenovic A, Welsh P, Woodward R, Struthers AD, Jardine AG, Patel RK, Berry C, Mark PB.

Kidney Int. 2016 Oct;90(4):845-52. doi: 10.1016/j.kint.2016.06.014. Epub 2016 Aug 5.

3.

Research cardiac magnetic resonance imaging in end stage renal disease - incidence, significance and implications of unexpected incidental findings.

Rutherford E, Weir-McCall JR, Patel RK, Houston JG, Roditi G, Struthers AD, Jardine AG, Mark PB.

Eur Radiol. 2017 Jan;27(1):315-324. Epub 2016 Apr 7.

4.

Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease.

Solbu MD, Thomson PC, Macpherson S, Findlay MD, Stevens KK, Patel RK, Padmanabhan S, Jardine AG, Mark PB.

BMC Nephrol. 2015 Dec 1;16:194. doi: 10.1186/s12882-015-0187-1.

5.

Proceedings of the 13th international transplantation symposia: mTOR-inhibition: what have we learned and how so we best apply the learning.

Jardine AG.

Transplant Res. 2015 Dec 22;4(Suppl 1):4. doi: 10.1186/s13737-015-0027-7. eCollection 2015 Dec 22. No abstract available.

6.

Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome-a single-center study.

Patel RK, Pennington C, Stevens KK, Taylor A, Gillis K, Rutherford E, Johnston N, Jardine AG, Mark PB.

Transplant Res. 2014 Dec 3;3(1):20. doi: 10.1186/s13737-014-0020-6. eCollection 2014 Dec 3.

7.

BP targets in renal transplant recipients: too high or too low?

Holdaas H, Jardine AG.

J Am Soc Nephrol. 2014 Jul;25(7):1371-3. doi: 10.1681/ASN.2014020177. Epub 2014 Mar 13. No abstract available.

8.

Inter-study reproducibility of arterial spin labelling magnetic resonance imaging for measurement of renal perfusion in healthy volunteers at 3 Tesla.

Gillis KA, McComb C, Foster JE, Taylor AH, Patel RK, Morris ST, Jardine AG, Schneider MP, Roditi GH, Delles C, Mark PB.

BMC Nephrol. 2014 Jan 31;15:23. doi: 10.1186/1471-2369-15-23.

9.

Bring on the weekend - Improving the quality of junior doctor weekend handover.

Jardine AG, Page T, Bethune R, Mourant P, Deol P, Bowden C, Dahill M, Mische C, Cornish N, Sanders V, Lee J, Bethune R.

BMJ Qual Improv Rep. 2014 Jan 8;2(2). pii: u202379.w1297. doi: 10.1136/bmjquality.u202379.w1297. eCollection 2014 Jan 8.

10.

Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma.

Rollag H, Ueland T, Asberg A, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P.

PLoS One. 2013 Apr 8;8(4):e60767. doi: 10.1371/journal.pone.0060767. Print 2013.

11.

Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes.

Schneider A, Schneider MP, Scharnagl H, Jardine AG, Wanner C, Drechsler C.

BMC Nephrol. 2013 Mar 22;14:67. doi: 10.1186/1471-2369-14-67.

12.

Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients.

Holme I, Fellström BC, Jardine AG, Hartmann A, Holdaas H.

Clin J Am Soc Nephrol. 2013 Feb;8(2):241-7. doi: 10.2215/CJN.03760412. Epub 2012 Nov 15.

13.

Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy.

Emery VC, Manuel O, Asberg A, Pang X, Kumar D, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Gahlemann CG, Humar A.

J Clin Virol. 2012 May;54(1):56-60. doi: 10.1016/j.jcv.2012.01.015. Epub 2012 Mar 10.

14.

Fibroblast growth factor 23 predicts left ventricular mass and induces cell adhesion molecule formation.

Stevens KK, McQuarrie EP, Sands W, Hillyard DZ, Patel RK, Mark PB, Jardine AG.

Int J Nephrol. 2011;2011:297070. doi: 10.4061/2011/297070. Epub 2011 Aug 9.

15.

Rosuvastatin in diabetic hemodialysis patients.

Holdaas H, Holme I, Schmieder RE, Jardine AG, Zannad F, Norby GE, Fellström BC; AURORA study group..

J Am Soc Nephrol. 2011 Jul;22(7):1335-41. doi: 10.1681/ASN.2010090987. Epub 2011 May 12.

16.

Microvolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy.

Patel RK, Mark PB, Halliday C, Steedman T, Dargie HJ, Cobbe SM, Jardine AG.

Clin J Am Soc Nephrol. 2011 Mar;6(3):519-27. doi: 10.2215/CJN.06370710. Epub 2010 Nov 18.

17.

Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation.

Patel RK, Jardine AG, Mark PB, Cunningham AF, Steedman T, Powell JR, McQuarrie EP, Stevens KK, Dargie HJ, Jardine AG.

Am J Kidney Dis. 2010 Jun;55(6):1088-96. doi: 10.1053/j.ajkd.2009.12.033. Epub 2010 Mar 25.

18.

Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.

Patel RK, Oliver S, Mark PB, Powell JR, McQuarrie EP, Traynor JP, Dargie HJ, Jardine AG.

Clin J Am Soc Nephrol. 2009 Sep;4(9):1477-1483. doi: 10.2215/CJN.03350509.

19.

Ten years experience of in-center thrice weekly long overnight hemodialysis.

Powell JR, Oluwaseun O, Woo YM, Padmanabhan N, Narasinghan E, Latta C, Tortolano J, Jardine AG, Geddes CC.

Clin J Am Soc Nephrol. 2009 Jun;4(6):1097-101. doi: 10.2215/CJN.06651208. Epub 2009 May 21.

20.

Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease.

Mark PB, Doyle A, Blyth KG, Patel RK, Weir RA, Steedman T, Foster JE, Dargie HJ, Jardine AG.

J Cardiovasc Magn Reson. 2008 Aug 18;10:39. doi: 10.1186/1532-429X-10-39.

Supplemental Content

Loading ...
Support Center